Brief: India's Mangalam Drugs & Organics March Quarter Profit Falls
May 28 (Reuters) - Mangalam Drugs and Organics Ltd
MADR.NS :
* MARCH QUARTER NET PROFIT 30.6 MILLION RUPEES VERSUS PROFIT
65.1
MILLION RUPEES YEAR AGO
* MARCH QUARTER REVENUE FROM OPERATIONS 672 MILLION RUPEES
VERSUS
829.1 MILLION RUPEES YEAR AGO
Source text - https://bit.ly/2scRq5R
Further company coverage: MADR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangalam Drugs and Organics
See all newsBrief: Mangalam Drugs And Organics Ltd Defaulted On Loan Obligations To Bank Of Baroda And Bank Of Maharashtra
Brief: Mangalam Drugs And Organics Defaults On Loans Obligations To Bank Of Baroda And Bank Of Maharashtra Over 30 Days
Brief: Mangalam Drugs And Organics Defaults On Loan Obligations To Bank Of Baroda, Bank Of Maharashtra
Brief: Mangalam Drugs And Organics Names Jeevan M. Dalvi As CFO
Brief: Mangalam Drugs And Organics Gets Order Worth 150 Million Rupees